共 87 条
[1]
Kucukmetin A(2010)Palliative surgery versus medical management for bowel obstruction in ovarian cancer Cochrane Database Syst Rev 7 CD007792-9
[2]
Naik R(2009)A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer Oncologist 14 835-9
[3]
Galaal K(2005)Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer J Pain Symptom Manage 30 563-5
[4]
Bryant A(2005)Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis Int J Gynecol Cancer 15 830-13
[5]
Dickinson HO(2003)Palliative surgery for bowel obstruction in recurrent ovarian cancer: an updated series Gynecol Oncol 89 306-92
[6]
Chi DS(2012)Octreotide for malignant bowel obstruction: twenty years after Crit Rev Oncol Hematol 83 388-9
[7]
Phaëton R(2008)Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction Jpn J Clin Oncol 38 354-34
[8]
Miner TJ(2000)Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial J Pain Symptom Manage 19 23-93
[9]
Kardos SV(1990)The management of inoperable gastrointestinal obstruction in terminal cancer patients Tumori. 76 389-6
[10]
Diaz JP(1991)Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction J Pain Symptom Manage. 6 484-2